ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...

New Rate Determination Track at IPEC would aim to increase transparency and provide affordable benchmark rates for standard ...

International companies are increasingly inking licensing deals with Chinese biotechs as concerns regarding drug pricing and ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

ViiV & MPP extend voluntary licensing long-acting injectable HIV treatment, Indian pharma to benefit: Our Bureau, Bengaluru Tuesday, July 15, 2025, 12:45 Hrs [IST] ViiV Healthcare ...

Plaintiffs allege that CRISP and its subsidiary willfully infringed on patented technology by launching a copycat product after terminating a long-standing licensing agreement.

Sun recieved approval from the US Food and Drug Administration for Leqselvi in July 2024. Soon after the regulator’s approval ...

The Jumptuit Group (TJG) is an AI research and development company working in the emerging field of Anticipatory Intelligence ...

New WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly ...

Aurobindo Pharma will manufacture and supply long-acting injectable HIV treatment, cabotegravir, across 133 countries through ...

Newly issued U.S. patent extends certepetide IP protection to 2040, with subsequent opportunity for patent term extension ...

The European Commission has issued an informal guidance letter to provide antitrust guidance for the creation of a licensing negotiation group in the ...